Skip to main content
SpringerLink
Log in

Thyroid function and plasma selenium in chronic uremic patients on hemodialysis treatment

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

It has been shown recently that Selenium (Se), an essential trace element for humans, is involved in the regulation of thyroid function, since the enzyme that catalyzes the liver conversion of the thyroid hormone T4 to the more active form T3 is a selenoenzyme. In chronic uremic patients, low blood Se levels as well as thyroid function abnormalities are often found. The present study was carried out to verify whether any correlation exists between Se levels and thyroid function, and to evaluate possible changes in hormonal pattern during Se supplementation in 10 chronic uremic patients on hemodialysis (HD) treatment. Se was supplemented orally as sodium selenite over six consecutive months. Basic plasma Se levels were significantly lower in patients than in normal controls. Right from the start of Se supplementation, plasma Se concentration promptly normalized and leveled off in the normal range throughout the study. Significant increase of FT3 and reduction of TSH levels were detected during Se supplementation. In Se-supplemented patients, a significant direct correlation was also found between reverse T3 (rT3) and TSH, and a significant inverse correlation was found between Se and TSH. Our results suggest that Se deficiency in chronic uremic patients represents a factor influencing the thyroid function and that the Se status should be determined in the evaluation of thyroid metabolism in these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. X. Chen, G. Yang, J. Chen, X. Chen, Z. Wen, and K. Ge, Studies on the relations of selenium and Keshan disease.Biol Trace Element Res. 2, 91–107 (1980).

    CAS  Google Scholar 

  2. L. Chong-Zheng, H. Jing-Rong, and L. Cai-Xia, Sodium selenite as a preventive measure for Kashin-Beck disease as avaluated in X-ray studies, inSelenium in Biology and Medicine, G. F. Combs, J. E. Spallhollz, O. A. Levander, and J. E. Olfield, eds., Van Nostram Reinold, New York, pp. 934–937 (1986).

    Google Scholar 

  3. C. L. Kien and H. E. Ganther. Manifestation of chronic selenium deficiency in a child receiving total parenteral nutrition.Am. J. Clin. Nutr. 32, 319–28 (1983).

    Google Scholar 

  4. G. Orndahl, A. Rindby, and E. Selin. Selenium therapy and myotonic dystrophy.Acta Med. Scand. 213, 237–239 (1983).

    Article  PubMed  CAS  Google Scholar 

  5. L. Hasselmark, R. Malmgren, O. Zetterstrom, and G. Unge. Selenium supplementation in intrinsic asthma.Allergy 48, 30–36 (1993).

    PubMed  CAS  Google Scholar 

  6. A. Peretz, J. Neve, J. Desmodt, M. Dramaix, and J. P. Famaey. Lymphocyte response is enhanced by supplementation of elderly subjects with selenium-enriched yeast.Am. J. Clin. Nutr. 53, 1323–1328 (1991).

    PubMed  CAS  Google Scholar 

  7. J. T. Salonen, G. Alfthan, J. Pikkarainen, J. K. Huttunen, and P. Puska. Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study.Lancet,1, 175–179 (1982).

    Article  Google Scholar 

  8. J. T. Rotruck, A. L. Pope, H. E. Ganter, A. B. Swanson, D. G. Hafeman, and W. G. Hoekstra. Selenium: biochemical role as a component of glutathione peroxidase.Science,179, 588–590 (1973).

    Article  PubMed  CAS  Google Scholar 

  9. D. Behne, A. Kyriakopoulos, H. Meinhold, and J. Kohrle. Identification of type I iodothironine 5′-deiodinase as a selenoenzyme.Biochem. Biophys. Res. Commun. 173, 1143–1149 (1990).

    Article  PubMed  CAS  Google Scholar 

  10. B. A. Zachara. Mammalian selenoproteins,J. Trace Element Electrolytes Health Dis. 6, 137–151 (1992).

    CAS  Google Scholar 

  11. G. Kallistratos, A. Evangelou, K. Seferiadis, P. Vezyrarki, and K. Barboutis. Selenium and hemodialysis: serum selenium levels in healthy persons, non cnacer and cancer patients with chronic renal failure.Nephron 41, 217–22 (1985).

    PubMed  CAS  Google Scholar 

  12. B. Dworkin, S. Weseley, W. S. Rosental, E. M. Schwartz, and L. Weiss. Diminished blood selenium levels in renal failure patients on dialysis: correlation with nutritional status.Am. J. Med. Sci. 293, 6–12 (1987).

    Article  PubMed  CAS  Google Scholar 

  13. M. D. Saint-Georges, D. J. Bonnefont, B. A. Bourely, M. C. T. Jaudon, P. Cereze, P. Chaumeil, C. Gard, and C. I. D'Auzac. Correction of selenium deficiency in hemodialyzed patients.Kidney Int. 36 (Suppl. 27), S274–279 (1989).

    Google Scholar 

  14. M. Bonomini, V. Manfrini, A. Marini, F. De Risio, L. Niri, H. Klinkmann, and A. Albertazzi. Hemodialysis with regenerated cellulosic membranes does not reduce plasma selenium levels in chronic uremic patients.Artif. Organs 1, 81–85 (1995).

    Article  Google Scholar 

  15. M. Bonomini, S. Forster, F. De Risio, J. Rychly, B. Nebe, V. Manfrini, H. Klinkmann, and A. Albertazzi. Effects of selenium supplementation on immune parameters in chronic uraemic patients on haemodialysis.Nephrol. Dial. Transplantion 10, 1654–1661 (1995).

    CAS  Google Scholar 

  16. R. F. Burk. Selenium in man, inTrace Elements in Human Health and Disease, vol. 2, A. S. Prasad, D. Oberleas, eds. Academic, New York pp. 105–133 (1976).

    Google Scholar 

  17. W. C. Willet, J. S. Morris, S. Pressel, J. O. Taylor, B. F. Polk, M. J. Stampfer, B. Rosner, K. Schneider, and C. G. Hames. Prediagnostic serum selenium and risk of cancer.Lancet 1, 130–134 (1983).

    Article  Google Scholar 

  18. M. Bonomini, S. K. Mujais, P. Ivanovich, and H. Klinkmann. Selenium in uremia: culprit or bystander?Nephron 60, 385–389 (1992).

    PubMed  CAS  Google Scholar 

  19. M. J. Berry, L. Banu, and P. R. Larsen, Type-I iodothyronine deiodinase is a selenocysteine-containing enzyme.Nature 349, 438–440 (1991).

    Article  PubMed  CAS  Google Scholar 

  20. B. Contemprè, N. L. Duale, J. E. Dumont, B. Ngo, A. T. Diplock, and J. Vanderpas. Effect of selenium supplementation on thyroid hormone metabolism in an iodine and selenium deficient population.Clin. Endocrinol. 36, 579–583, (1992).

    Google Scholar 

  21. M. J. Berry and P. R. Larsen. The role of selenium in thyroid hormone action.Endocr. Rev. 12, 207–219 (1992).

    Article  Google Scholar 

  22. V. S. Lim, V. S. Fang, A. I. Katz, and S. Refetoff. Thyroid dysfunction in chronic renal failure: a study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine.J. Clin. Invest. 60, 522–534 (1977).

    PubMed  CAS  Google Scholar 

  23. G. Ramirez, P. A. Bittle, H. Sanders, and B. B. Bercu. Hypothalamo-hypophyseal thyroid and gonadal function before and after erythropoietin therapy in dialysis patients.J. Clin. Endocrinol. Metab. 74, 517–524 (1992).

    Article  PubMed  CAS  Google Scholar 

  24. M. J. Hardy, S. S. Ragbeer, and L. Nascimento. Pituitary-thyroid function in chronic renal failure, assessed by a highly sensitive thyrotropin assay.J. Clin. Endocrinol. Metab. 66, 233–236 (1988).

    Article  PubMed  CAS  Google Scholar 

  25. H. J. Mehta, L. J. Joseph, K. B. Desai, M. N. Mehta, A. M. Samuel, A. F. Almeida, and V. N. Acharya. Total and free thyroid hormone levels in chronic renal failure.J. Postgrad. Med. 37, 79–83, (1991).

    PubMed  CAS  Google Scholar 

  26. V. Bonomini, G. Orsoni, M. A. Sorrentino, and P. Todeschini. Hormonal changes in hemodialysis.Blood Purif. 8, 54–68 (1990).

    Article  PubMed  CAS  Google Scholar 

  27. L. Wartofsky and K. D. Burman. Alterations in thyroid function in patients with systemic ilness: the euthyroid sick syndrome.Endocr. Rev. 3, 164–217 (1982).

    PubMed  CAS  Google Scholar 

  28. T. K. Wong and J. M. Hershman. Changes in thyroid function in nonthyroid illness.Trends Endocrinol. Metab. 3, 8–12 (1992).

    Article  CAS  PubMed  Google Scholar 

  29. S. La Franchi. Thyroid function in children with chronic renal failure.J. Pediatr. 118, 896–98 (1991).

    Article  Google Scholar 

  30. Y. Kijima, K. Ozawa, T. Nakanishi, Y. Fukudome, T. Shoji and T. Sasaoka. Selenium deficit affects thyroid hormone metabolism in chronic dialysis patients, XII International Congress of Nephrology, Madrid (Spain), abstract book, 547 (1995).

  31. S. H. Tikanoja, A. Joutti, and B. K. Liewendahl. Association between increased concentrations of free thyroxine and unsaturated free fatty acid in non-thyroidal illness: role of albumin,Clin. Chim. Acta 179, 33–44 (1989).

    Article  PubMed  CAS  Google Scholar 

  32. M. Weissel and H. K. Stummvoll. Serum reverse triiodothyronine (3,3′,5′-l-triiodothyronione) in end-stage renal failure.Nephron 28, 303–304 (1981).

    PubMed  CAS  Google Scholar 

  33. F. Van Lente and R. Daher. Plasma selenium concentrations in patients with euthyroid sick syndrome.Clin. Chem. 38, 1885–1888 (1992).

    PubMed  Google Scholar 

  34. G. A. Grent and J. M. Hershman. Effects of nonthyroidal illness on thyroid function tests, inThe Thyroid Gland L. Van Middleworth, ed., Year Book, Chicago, pp. 83–110 (1986).

    Google Scholar 

  35. S. Lio and F. Monaco. Thyroid function in nonthyroidal illness, inThyroid Diseases. Clinical Fundamentals and Therapy. F. Monaco, M. A. Satta, B. Shapiro, and L. Troncone, eds., CRC, Boca Raton, pp. 587–593 (1993).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University “G. D'Annunzio” Centro Se.Bi., Via dei Vestini, 66013, Chieti scalo, Italy

    Giorgio Napolitano (Chair of Endocrinology), Mario Bonomini (Chair of Nephrology), Giuseppina Bomba, Ines Bucci, Valentina Todisco, Alberto Albertazzi & Fabrizio Monaco

Authors
  1. Giorgio Napolitano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mario Bonomini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giuseppina Bomba
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ines Bucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Valentina Todisco
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alberto Albertazzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Fabrizio Monaco
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Napolitano, G., Bonomini, M., Bomba, G. et al. Thyroid function and plasma selenium in chronic uremic patients on hemodialysis treatment. Biol Trace Elem Res 55, 221–230 (1996). https://doi.org/10.1007/BF02785281

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02785281

Index Entries

Search

Navigation